DELOS CAPITAL

delos-capital-logo

Delos Capital is a healthcare-focused fund, investing in growth platforms and relevant innovation in both therapeutic and medical technology areas. Delos Capital seeks to achieve returns by supporting these companies in their development and also helping to create additional value from collaboration between these companies.

#People #Financial #More

DELOS CAPITAL

Social Links:

Industry:
Health Care

Founded:
2014-01-01

Status:
Active

Contact:
+852 3912 0500

Technology used in webpage:
SPF Font Awesome Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator


Current Employees Featured

henry-chen_image

Henry Chen
Henry Chen Founder and Managing Partner @ Delos Capital
Founder and Managing Partner
2014-12-01

Investments List

Date Company Article Money raised
2021-11-03 Antios Therapeutics Delos Capital investment in Series B - Antios Therapeutics 75 M USD
2021-04-12 Antios Therapeutics Delos Capital investment in Series B - Antios Therapeutics 96 M USD
2019-09-23 Curamir Therapeutics Delos Capital investment in Series A - Curamir Therapeutics 10 M USD
2018-11-27 Antios Therapeutics Delos Capital investment in Series A - Antios Therapeutics 25 M USD
2017-06-29 LipoSeuticals Delos Capital investment in Series A - LipoSeuticals N/A
2015-05-12 Atia Vision Delos Capital investment in Series B - Atia Vision 3 M USD

More informations about "Delos Capital"

Delos Capital - A private equity firm based in New York …

Delos Capital is a private investment and financial advisory firm led by owners who have decades of experience investing in and advising on cutting-edge, complex transactions. Our collective knowledge brings unique perspectives, …See details»

Delos Capital - Crunchbase Investor Profile

Delos Capital is a lower-middle market private equity investment firm based in New York City. The Fund was formed in 2013 to invest in complex processes through Control Buyouts, Strategic Partnerships and Distressed Buyouts in …See details»

Delos Capital - Investments, Portfolio & Company Exits - Crunchbase

Jan 6, 2023 Delos Capital 's most notable exits include Zenas BioPharma, Syndax Pharmaceuticals, and Clover Biopharmaceuticals. Which industries has this organization had …See details»

Home | Delos Capital Advisors | Dallas

Delos Capital Advisors - Your Trusted Partner in Wealth Management. Discover our comprehensive financial solutions, personalized strategies, and exceptional service. Let our …See details»

Expert Biotech Investment Team| Delos Capital

Delos Capital. Approach. Team. Portfolio. News. Contact. Team We are a partnership comprised of seasoned entrepreneurs and scientists, committed to investing our time and capital into a positive and lasting impact on human …See details»

Biotech Investment Process| Delos Capital

Delos Capital. Approach. Team. Portfolio. News. Contact. Approach Our rigorous investment process combines a deep understanding of biology, unmet needs in medicine, and building high-performing companies to bring medical …See details»

Delos Capital - Crunchbase Investor Profile & Investments

Delos Capital is a healthcare-focused fund, investing in growth platforms and relevant innovation in both therapeutic and medical technology areas. Delos Capital seeks to achieve returns by …See details»

Delos Capital - raizer.app

A lower-middle market private equity investment firm based in New York City Learn which startups Delos Capital invests in, number of investmenst, exits, and contact info to pitch your startup.See details»

A private equity firm based in New York City - Delos Capital

Matt Constantino is Managing Partner of Delos Capital and has more than 25 years of experience working with management teams, CEOs and boards of privately-held businesses. Previously, …See details»

Delos Capital - Israeli VC and Private Equity | Startup Nation Finder

Work Email* (please provide your email in the organization) Position* Notes. Send Create Free Account. Create Free Account. 8 Characters, Uppercase letter (A-Z), Lowercase letter (a-z), …See details»

Delos Capital - LinkedIn

Delos Capital is a life sciences investment firm. Our team draws upon diverse skills and a global network to support ground-breaking innovations that will improve lives around the world.See details»

Henry Chen - Delos Capital

Henry founded Delos Capital in 2015 and serves as its Managing Partner. Prior to establishing Delos, Mr. Chen was a Partner and Co-Head of Asia at Permira, a European private equity …See details»

Delos Capital - Contacts, Employees, Board Members ... - Crunchbase

Delos Capital has 3 current employee profiles, including CFO/COO Sanjay Sanghoee. Sanjay Sanghoee CFO/COO. Matt Constantino Founding Partner. Tim Xiao Partner. Unlock even …See details»

Andrew Schweibold — Delos Capital - A private equity firm based …

Schweibold previously worked for firms such as Apollo Global Management, GTCR Golder Rauner, Lazard and Vision Capital. He has a BBA from the Stephen M. Ross School of …See details»

Delos Capital Announces Formation of Financial Advisory Group …

Jul 9, 2024 Delos Capital is a private equity and financial advisory firm based in New York. We draw upon our experience having invested in and advised on some of the largest and most …See details»

Biotechnology Investment Portfolio | Delos Capital

Delos Capital. Approach. Team. Portfolio. News. Contact. Portfolio Companies Our investments are partnerships. We support visionary entrepreneurs with our capital and deep life sciences …See details»

Delos Capital - Funding, Financials, Valuation & Investors

Delos Capital has raised a total of $525M across 2 funds, their latest being Delos Investment Fund II. This fund was announced on Apr 6, 2018 and raised a total of . obfuscated. …See details»

A private equity firm based in New York City - Delos Capital

Remy Griggs has over 7 years of investment banking experience. Prior to joining Delos, he was a member of the Leveraged Finance group at BNP Paribas, where he originated leveraged loan …See details»

Lee Cooper - Delos Capital

Lee joined Delos Capital as a Managing Director in 2024. He is committed to helping advance meaningful new medicines for patients. Before joining Delos, Lee was a life sciences investor …See details»